These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
583 related items for PubMed ID: 31547815
1. Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy. Liu Y, Liu X, Jia J, Zheng J, Yan T. J Transl Med; 2019 Sep 23; 17(1):320. PubMed ID: 31547815 [Abstract] [Full Text] [Related]
3. ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome. Liu Y, Wang F, Zhang Y, Jia J, Yan T. J Cell Mol Med; 2020 Sep 23; 24(18):10493-10500. PubMed ID: 32677771 [Abstract] [Full Text] [Related]
4. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. Camilla R, Suzuki H, Daprà V, Loiacono E, Peruzzi L, Amore A, Ghiggeri GM, Mazzucco G, Scolari F, Gharavi AG, Appel GB, Troyanov S, Novak J, Julian BA, Coppo R. Clin J Am Soc Nephrol; 2011 Aug 23; 6(8):1903-11. PubMed ID: 21784819 [Abstract] [Full Text] [Related]
5. Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability. Hastings MC, Moldoveanu Z, Julian BA, Novak J, Sanders JT, McGlothan KR, Gharavi AG, Wyatt RJ. Clin J Am Soc Nephrol; 2010 Nov 23; 5(11):2069-74. PubMed ID: 20634323 [Abstract] [Full Text] [Related]
6. TLR7 in B cells promotes renal inflammation and Gd-IgA1 synthesis in IgA nephropathy. Zheng N, Xie K, Ye H, Dong Y, Wang B, Luo N, Fan J, Tan J, Chen W, Yu X. JCI Insight; 2020 Jul 23; 5(14):. PubMed ID: 32699192 [Abstract] [Full Text] [Related]
8. Significance of serum galactose deficient IgA1 as a potential biomarker for IgA nephropathy: A case control study. Bagchi S, Lingaiah R, Mani K, Barwad A, Singh G, Balooni V, Bhowmik D, Agarwal SK. PLoS One; 2019 Jul 23; 14(3):e0214256. PubMed ID: 30917188 [Abstract] [Full Text] [Related]
9. Potential diagnostic biomarkers for IgA nephropathy: a comparative study pre- and post-tonsillectomy. Xie YX, He LY, Chen X, Peng XF, Ye MY, Zhao YJ, Yan WZ, Liu C, Shao J, Peng YM. Int Urol Nephrol; 2016 Nov 23; 48(11):1855-1861. PubMed ID: 27465795 [Abstract] [Full Text] [Related]
11. Changes E3 ubiquitin protein ligase 1 gene mRNA expression correlated with IgA1 glycosylation in patients with IgA nephropathy. Liu Y, Zheng J, Jia J, Li H, Hu S, Lin Y, Yan T. Ren Fail; 2019 Nov 23; 41(1):370-376. PubMed ID: 31057023 [Abstract] [Full Text] [Related]
12. C1GALT1 expression is associated with galactosylation of IgA1 in peripheral B lymphocyte in immunoglobulin a nephropathy. Xing Y, Li L, Zhang Y, Wang F, He D, Liu Y, Jia J, Yan T, Lin S. BMC Nephrol; 2020 Jan 15; 21(1):18. PubMed ID: 31941451 [Abstract] [Full Text] [Related]
17. Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis. Zhang X, Xie X, Shi S, Liu L, Lv J, Zhang H. Nephrol Dial Transplant; 2020 Dec 04; 35(12):2117-2123. PubMed ID: 31377786 [Abstract] [Full Text] [Related]
18. A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases. Yanagawa H, Suzuki H, Suzuki Y, Kiryluk K, Gharavi AG, Matsuoka K, Makita Y, Julian BA, Novak J, Tomino Y. PLoS One; 2014 Dec 04; 9(5):e98081. PubMed ID: 24858067 [Abstract] [Full Text] [Related]